BioCina
Sandeep More is an experienced quality management professional in the biopharmaceutical sector, currently serving as Quality Manager at BioCina since February 2024. Prior to this role, Sandeep held the position of Senior Manager Quality at Viatris, overseeing quality assurance across multiple biopharma manufacturing sites and managing change, incidents, product launches, market complaints, recalls, and audit compliance. Sandeep also worked as a Senior Quality Assurance Manager at Intas Pharmaceuticals Ltd., leading the Quality Management System and Product Life Cycle Management teams. Beginning a career as an Executive, Sandeep advanced to Associate Quality Assurance Manager at Biocon Biologics, focusing on process assurance, validation, CAPA management, and compliance. Sandeep holds a Master's degree in Biotechnology from the Birla Institute of Technology and Science, Pilani, and a Bachelor's in Biotechnology from KIT's College of Engineering Kolhapur.
This person is not in any teams
BioCina
BioCina is a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), offering highest-quality, cost-effective cell line, process, analytical and formulation development, and cGMP clinical & commercial manufacturing for the microbial, pDNA and mRNA modalities. BioCina’s first facility in Adelaide, South Australia is a testament to the quality of its work. It has a rich history of developing and manufacturing both clinical and commercial drug substance, backed by most critical SME’s having an average tenure of 15+ years at the site. BioCina boasts an elite quality record having successfully passed regulatory inspections by the US FDA, EMA and Health Canada. It is licensed by the Australian TGA for cGMP manufacturing of bulk drug substance or active intermediates. Through a partnership with NovaCina, BioCina offers clients a highest-quality fill-and-finish solution. BioCina is proud to have clients globally, including U.S., Europe, and the Asia Pacific. Because BioCina is not a drug developer, it only serves clients' products. As one of the fastest growing companies in the biopharmaceutical industry across Australia, BioCina was awarded the 2024 South Australia “Emerging Business of the Year” award. Learn more at https://biocina.com.